What is the APOC3 gene?
Apolipoprotein C-III regulation of triglyceride-rich lipoprotein metabolism.
How APOC3 affects metabolism
When APOC3-related function is shifted, the practical effect is interpreted through lipoprotein transport, triglyceride-rich particles, LDL clearance, or liver lipid handling. This does not mean the pathway is active or impaired right now; it means the gene can help prioritize what to check next.
What happens when APOC3 is altered
Altered APOC3 signal should be treated as a DNA-based tendency, not a diagnosis. 2 claims currently pass the report-use gate. The useful question is whether symptoms, labs, and lifestyle context line up with the pathway signal.
Curated SNP evidence for APOC3
These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.
Evidence-backed report connection
APOC3 currently has 2 curated SNPs, 2 claim-level scores, and 2 claims eligible for pathway scoring.
Open the sample reportrs138326449APOC3 splice LoF1 claims · 2 study rows
biomarker tendency · A
triglyceride-rich lipoprotein tendency
rs138326449 A carrier status is associated with lower triglyceride-rich lipoprotein tendency.
APOC3 rs138326449 A is staged as a rare loss-of-function lipid biomarker allele.
Show study evidence
rs5128APOC3 SstI / 3238C>G1 claims · 2 study rows
biomarker tendency · G carrier
triglyceride-rich lipoprotein tendency
rs5128 G / APOC3 SstI carrier status is associated with higher plasma APOC3 and triglyceride-rich lipoprotein tendency.
APOC3 rs5128 G is staged as a common APOC3 lipid-biomarker allele associated with higher APOC3 and triglyceride tendency.
Show study evidence
Common symptoms people report
- unexpected cholesterol or triglyceride results
- family context around lipid markers
- unclear ApoB, LDL-C, HDL-C, or triglyceride patterns
Biomarkers to validate
ApoB
Shows the number of atherogenic particles more directly than total cholesterol.
LDL-C, HDL-C, and triglycerides
Gives the basic lipid pattern that DNA can help contextualize.
Lp(a) or liver enzymes when relevant
Adds context for inherited lipid risk or liver lipid handling.
Where DNA analysis helps
DNA helps decide whether APOC3 deserves attention inside the broader Lipids pathway. It is most useful when combined with biomarkers instead of used as a standalone answer.
Example interpretation
APOC3 may add context to lipoprotein transport, triglyceride-rich particles, LDL clearance, or liver lipid handling, especially when its SNP evidence lines up with other genes in the same pathway.
Suggested validation: ApoB.
What to do next
- Review the Lipids pathway result before interpreting APOC3 on its own.
- Use relevant biomarkers to confirm whether this DNA tendency is visible in current biology.
- Treat supplement or nutrition decisions as follow-up steps only after the pattern fits symptoms or labs.
Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.
Get My DNA Report